InvestorsHub Logo
icon url

jbog

12/08/07 5:12 PM

#4468 RE: biophud #4465

bio,

On the last Conference Call Eric mentioned that it was Mr. Johnson who was driving Imclones partnering outside the normal cancer settings. I believe he was referring to autoimmune and opthamology fields.